本文に飛ぶ

年 〜
年

検索結果 10 件

Guidance for industry [microform] : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products

Guidance for industry [microform] : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products
マイクロ図書
1995<YCA-HE 20.4708:IN 2/2>
国立国会図書館
  • 件名Drugs -- Testing -- Government policy -- United States Pharmaceutical policy -- Unit...

The need for FDA regulatory reform to protect the health and safety of Americans : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 9, 1995

The need for FDA regulatory reform to protect the health and safety of Americans : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, June 9, 1995
マイクロ図書
1996<YCA-Y 4.G 74/7:F 73/19>
国立国会図書館
  • 件名...Administration Drugs -- Testing -- Government policy -- United States New products -- Government po...

Addressing the FDA's performance, efficiency, and use of resources : hearings of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, first session ... March 19 and April 11, 1997 (S. hrg. ; 105-23)

Addressing the FDA's performance, efficiency, and use of resources : hearings of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, first session ... March 19 and April 11, 1997 (S. hrg. ; 105-23)
マイクロ図書
1997<YCA-Y 4.L 11/4:S.HRG.105-23>
国立国会図書館
  • 件名...Administration Drugs -- Testing -- Government policy -- United States Pharmaceutical industry -- Go...

Science, politics, and the pharmaceutical industry : controversy and bias in drug regulation / John Abraham.

Science, politics, and the pharmaceutical industry : controversy and bias in drug regulation / John Abraham.
紙図書
UCL Press1995.<EG237-A13>
国立国会図書館
  • 件名...アメリカ合衆国. イギリス. Drugs -- Testing -- Government policy -- United States. Drugs -- Testing -- Governme...

New drug approval process : the global challenge 3rd ed.

New drug approval process : the global challenge 3rd ed.
紙図書
edited by Richard A. GuarinoM. Dekkerc2000
全国の図書館
  • 件名Drugs -- Testing -- Standards Drugs -- Testing -- Government policy -- United States New products -- Government po...
  • 件名（識別子）Drugs -- Testing -- Standards Drugs -- Testing -- Government policy -- United States New products -- Government po...

New drug approval process : clinical and regulatory management / edited by Richard A. Guarino. (Drugs and the pharmaceutical sciences ; v. 30)

New drug approval process : clinical and regulatory management / edited by Richard A. Guarino. (Drugs and the pharmaceutical sciences ; v. 30)
紙図書
Dekkerc1987.<SD61-A6>
国立国会図書館
  • 件名... -- Standards. Drugs -- Testing -- Government policy -- United States. New products -- Government p...

Science, politics, and the pharmaceutical industry : controversy and bias in drug regulation : hbk : pbk

Science, politics, and the pharmaceutical industry : controversy and bias in drug regulation : hbk : pbk
紙図書
John AbrahamUCL press1995
全国の図書館
  • 件名Drugs -- Testing -- Government policy -- United States Drugs -- Testing -- Governmen...
  • 件名（識別子）Drugs -- Testing -- Government policy -- United States Drugs -- Testing -- Governmen...

New drug approval process 2nd ed., rev. & expanded

New drug approval process 2nd ed., rev. & expanded
紙図書
edited by Richard A. GuarinoM. Dekkerc1993
全国の図書館
  • 件名Drugs -- Testing -- Standards Drugs -- Testing -- Government policy -- United States New products -- Government po...
  • 件名（識別子）Drugs -- Testing -- Standards Drugs -- Testing -- Government policy -- United States New products -- Government po...

New drug approval process : clinical and regulatory management

New drug approval process : clinical and regulatory management
紙図書
edited by Richard A. GuarinoDekkerc1987
全国の図書館
  • 件名Drugs -- Testing -- Standards Drugs -- Testing -- Government policy -- United States New products -- Government po...
  • 件名（識別子）Drugs -- Testing -- Standards Drugs -- Testing -- Government policy -- United States New products -- Government po...

Risk-benefit/cost-benefit : improving government regulation of approval of new drugs

Risk-benefit/cost-benefit : improving government regulation of approval of new drugs
紙図書
remarks by Rita Ricardo-Campbell, presented at the World Congress on Health and Economics [i.e. World Congress on Health Economics] Leyden University, Leyden, The Netherlands, September 9, 1980Hoover Institution, Stanford University1980
全国の図書館
  • 件名... United States Drugs -- Testing -- Government policy -- United States Drugs -- Cost effectiveness D...
  • 件名（識別子）... United States Drugs -- Testing -- Government policy -- United States Drugs -- Cost effectiveness D...

検索結果は以上です。

RSS